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A Danish–Swedish collaboration was established to 
identify and classify a Danish cohort of patients with 
epidermolytic ichthyosis, also known as epidermolytic 
hyperkeratosis. Patients were recruited from 5 derma-
tology departments in Denmark, and data were obtained 
using a structured questionnaire and a systematic exa-
mination together with photographs, histopathological 
descriptions and blood samples for mutational analysis. 
Sixteen patients from 12 families with generalized or 
naevoid epidermolytic ichthyosis and ichthyosis bullosa 
of Siemens were identified. Five families had mutations 
in K1 and 6 families had mutations in K10. Nine patients 
had been treated with systemic retinoids (etretinate, aci-
tretin, isotretinoin or alitretinoin), but only 3 patients 
had acceptable treatment responses and chose to conti-
nue therapy. In conclusion epidermolytic ichthyosis is 
a rare disease with a prevalence of approximately 1 in 
350,000 in Denmark and a high percentage of de novo 
mutations (75%). We identified 4 novel disease-causing 
mutations. Key words: genomic DNA sequencing; epider-
molytic ichthy osis; epidermolytic hyperkeratosis; phenoty-
pic variation.
(Accepted June 4, 2012.)
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Epidermolytic ichthyosis (EI; OMIM 113800), also 
referred to as epidermolytic hyperkeratosis or bullous 
congenital ichthyosiform erythroderma, is a rare kerati-
nization disorder caused by dominant negative mutations 
in keratin genes KRT1 and KRT10, leading to an unstable 
cytoskeleton of epithelial keratinocytes and epidermal 
hyperkeratosis (1). In contrast to most other ichthyoses, 
the histopathological picture of EI is distinctive, with 
hyperkeratosis, acanthosis and characteristic clumping 
of tonofilaments, intracellular vacuolization and intra-
epidermal blisters. 
Children with generalized EI are usually born with 
erythroderma, extensive blistering and denuded skin 
that later changes into a more ichthyotic phenotype with 
rippled hyperkeratosis mainly on flexural surfaces. The 
bullous component gradually becomes less prominent, 
but patients may continuously have problems with 
blistering, especially after trauma or skin infections. 
In addition, some patients also have palmoplantar ke-
ratoderma (PPK).
The naevoid form of EI, linear epidermolytic ichthyo-
sis (LEI), occurs as epidermal naevi with cytoskeletal 
abnormalities of epidermolytic hyperkeratosis represen-
ting somatic mosaicism. In case of gonadal mosaicism 
the offspring of the patient may develop full-blown EI. 
Therefore epidermolytic naevi are included in the most 
recent classification of keratinopathic ichthyosis (1).
Ichthyosis bullosa of Siemens (IBS) resembles EI, 
but has a milder phenotype with less hyperkeratosis, 
more superficial blistering and no PPK. Mutations in 
K2, a keratin expressed later during differentiation, 
cause IBS (1, 2). 
In this study we describe the clinical subtypes and 
mutational findings in a cohort of 16 Danish patients 
with EI/IBS. 
PATIENTS AND METHODS
Patients and samples
Patients were identified through a national study of congenital 
ichthyosis undertaken in 2004 to 2006 by 3 of the authors (AB, 
AG and FB). In order to trace all patients seen in Denmark 
from 1984 to 2003 with a diagnosis of congenital ichthyosis, 
contact was established with all 6 departments of dermatology. 
Patients with a clinical phenotype consistent with EI or IBS 
were included in this study. 
Written informed consent was obtained from all patients 
according to approval by the Danish ethics committee (jr. no. 
VF20040178).
A complete medical history was obtained from all patients 
using a structured questionnaire. In order to obtain a uniform 
classification, patients were systematically examined by at least 
2 of 3 authors (AB, AG and FB) together with a local dermato-
logist to give the best clinical classification. Photographs were 
taken, previous histopathological descriptions were reviewed 
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and new skin biopsies for light or electron microscopy were 
taken in case of diagnostic doubt. Blood samples were obtai-
ned for DNA extraction and mutational analysis in KRT1 and 
KRT10. In patients where no pathogenic mutation was identi-
fied, KRT2 was also examined.
Genetic analyses
Genomic DNA (gDNA) was extracted from 2 ml ethylenedia-
minetetraacetic acid (EDTA) blood using E:Z:N:A:MidiKit`s 
(Omega Bio-Tek Norcross, GA, uSA). 100 ng of gDNA was 
used for PCR amplification of all KRT1 exons and the hot-spot 
regions in KRT2 and KRT10. The DNA was added to a mix 
of 1×Taq buffer, 0.2 mM of each dNTP, forward and reverse 
primers (10 µM), 2.5 mM MgCl2 and 0.05 u Taq polymerase 
(Applied Biosystems, Stockholm, Sweden) in a total volume 
of 50 µl.
All patients were initially screened for mutations in hotspot 
regions of KRT1 and KRT10 by denaturing high-performance 
liquid chromatography (HPlC) (Transgenomic, Omaha, 
USA). Before the analysis the PCR fragments were partially 
denaturated by decreasing the temperature from 94ºC to 40ºC 
during 30 min. An aliquot of PCR fragments was purified by 
using GTXtm PCr DNA and GelBand purification Kit (GE 
Healthcare, uppsala, Sweden) followed by DNA sequencing. 
Automated sequencing was done using Big Dye Terminator 
kit and analysed on an ABIPrism 377 DNA sequencer (Perkin-
Elmer Applied Biosystems, Foster City, CA, USA).
rESulTS
A total of 16 patients from 12 families fulfilled the 
inclusion criteria for EI/IBS. The symptoms varied in 
intensity from mild to severe and in 8 of the patients an 
associated PPK was observed (Table I). For 2 families, 
3 affected members were found in each family. In one 
of the families (number 5) an affected mother and 2 
children with EI were found (Fig. 1), and in the other 
family (number 6) EI was observed in 3 generations, 
starting with a naevoid lesion in the grandfather (Fig. 
S1; available from: http://www.medicaljournals.se/
acta/content/?doi=10.2340/00015555-1447).
Ten different disease-causing mutations were detec-
ted in 11 of the 12 families (Table I). Mutations in K1 
were found in 5 families, and 6 families had mutations 
in K10. Six of these mutations have been described 
previously (3–8). The remaining mutations are novel: 
3 point mutations with a non-conservative amino acid 
substitution (family numbers 1, 2 and 11) and 1 in-frame 
deletion of 30 bp in KRT1 exon 2 (family number 5). 
Although a substitution of amino acid 486 in K1 has 
been described previously (9, 10), our family number 
1 has a different point mutation, resulting in a different 
amino acid change in this position. The other 2 point 
mutations (family numbers 2 and 11) are located near 
previously reported disease-causing mutations in KRT1 
or KRT10 (4, 11). In family number 5, an in-frame 
deletion in KRT1 (p.His225_Phe234del) was found, 
which removes the last part of the L1 region and the 
beginning of region 1B of K1. There are no previous 
reports of such a mutation, but a point mutation causing 
PPK has been described in this region (12). The mother 
in family number 5 was born with erythroderma and 
bullae and later developed rippled hyperkeratosis in the 
flexural areas (Fig. 1A). She had a persistent tendency 
to blistering and erosions on pressure-prone areas (Fig. 
1B). She gave birth to 2 children with mild erythroderma 
and blistering at birth changing to more hyperkeratotic 
skin lesions within the first year of life. They all had 
white spongy soles and palms at birth (Fig. 1C), later 
developing into PPK. 
We could not identify a mutation explaining the 
naevoid skin lesions in the father of patient IX with 
EI due to KRT10 c.1333G>A. However, only blood 
leukocytes were available for analysis. Patient XVI, 
clinically and histopathologically diagnosed as IBS 
(Fig. S2; available from http://www.medicaljournals.
se/acta/content/?doi=10.2340/00015555-1447), had no 
identifiable KRT1, KRT2 or KRT10 mutation, except for 
a previously reported polymorphism, an 18-bp deletion 
in exon 1 of KRT2 (13).
DISCuSSION
We identified 16 Danish patients with generalized or 
naevoid EI and IBS, corresponding to a prevalence 
of approximately 1 in 350,000 in Denmark. This is 3 
times higher than the estimated prevalence in other 
Scandinavian countries (14), but similar to prevalence 
estimates of 1 in 100,000–300,000 reported in the 
literature (15, 16). 
The patients with generalized EI typically had 
disease onset from birth, with erythroderma and 
blisters with denuded skin areas (Fig. S3; avail able 
from: http://www.medicaljournals.se/acta/content/?
doi=10.2340/00015555-1447). Some patients subse-
quently developed mild flexural involvement, while 
others had generalized erythroderma with blistering/
erosion tendency continuing in adulthood, but over-
all symptoms improved with age. A few patients had 
very severe PPK with contractures (Fig. S4; available 
from http://www.medicaljournals.se/acta/content/?d
oi=10.2340/00015555-1447). 
In this study, the percentage of de novo mutations 
was very high; 75% compared with a previously repor-
ted spontaneous mutation rate of about 50% (15–18). 
The majority of reported mutations were heterozygous 
missense mutations. When mutations are located at the 
conserved helix boundary motifs, the helix initiation or 
termination peptides and the non-helical H1 domain of 
K1 and K10, they will result in severe EI (17, 19). In 
family number 5 with a moderate EI phenotype, a par-
tial deletion of l1 and 1B region in K1 was identified. 
Insertion/deletion mutations and splice site-defects or 
dinucleotide alterations in KRT10 have also been descri-
bed and more than 100 mutations in KRT1 and KRT10 
have already been reported (17, www.interfil.org). 
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All 6 patients with K1 mutations had PPK, while only 
1 out of 6 patients with K10 mutation had PPK. This 
is in accordance with earlier published studies (15, 17, 
20). The absence of PPK in patients with mutation in 
K10 is explainable by palmoplantar expression of K9, 
which is a functional substitute for K10. In our study 2 
unrelated females (patient XIII and XIV) had the same 
mutation in K10, but only one of them had a mild PPK, 
suggesting that other genetic or environmental factors 
also influence the phenotype. 
LEI is manifested as streaks of hyperkeratosis fol-
lowing the lines of Blaschko. LEI is caused by somatic 
mutations in K10, or rarely K1, arising post-zygotically 
during embryogenesis (21–23). Mutations have been de-
monstrated in keratinocytes from affected skin, whereas 
the mutations are absent in non-lesional skin and blood 
Table I. Summary of clinical and mutational data in 16 Danish patients with various types of epidermolytic ichthyosis (EI), showing 
those with KRT1 mutations at the top (new mutations are shown in bold)
Pat. No. 
Diagnosis
Sex/age 
(years)
Familial 
(family No.) Mutation Protein
Clinical presentation Histology showing EHK
At birth At inclusion in study LM EM
I
EI
M/34 No 
(1)
KRT1 c.1457T>A p.leu486Gln Blistering 
Erosions
Few erosions
Hyperkeratosis
PPK
yes yes
II
EI
M/20 No 
(2)
KRT1 c.1424T>C p.Leu475Proa Blistering 
Erosions
Focal blisters
Hyperkeratosis
PPK
yes ND
III
EI
M/27 No 
(3)
KRT1 c.1445A>G p.Tyr482Cys Erythroderma 
Blistering
Erythroderma
Blistering
Hyperkeratosis
PPK
yes yes
IV
EI
M/40 No 
(4)
KRT1 c.1465G>A p.Glu489Lys Blistering 
Erosions
Focal blisters
EHK
PPK
yes yes
V
EI
F/33 yes 
(5)
KRT1 c.673_702
del 30
p.His225_Phe
234dela
Erythroderma 
Blistering
Focal blisters
Hyperkeratosis
PPK
yes yes
VI
EI
M/3 yes 
(5)
KRT1 c.673_702
del 30
p.His225_Phe
234del
Erythroderma 
Blistering
Focal blisters
Hyperkeratosis
PPK
NT NT
VII
EI
F/1 yes 
(5)
NT Erythroderma 
Blistering
Erythroderma
Blistering
Hyperkeratosis
PPK
NT NT
VIII
LEI
M/65 yes 
(6)
No mutation found Naevoid/striate thickening 
of skin on right-sided 
extremities
Striate 
Hyperkeratosis 
yes NT
IX
EI
F/38 yes 
(6)
KRT10 c.1333G>A p.Glu445Lys Erythroderma 
Erosions
Focal blisters
Hyperkeratosis
Erosions
yes NT
X
EI
F/6 yes 
(6)
NT Erythroderma 
Erosions
Focal blisters
EHK
NT NT
XI
EI
M18 No 
(7)
KRT10 c.466C>T p.Arg156Cys Erythroderma Focal blisters
Hyperkeratosis
yes yes
XII
EI
M/3 No 
(8)
KRT10 c.466C>A p.Arg156Serb Erythroderma 
Erosions
Focal blisters
Hyperkeratosis
yes NT
XIII
EI
F/44 No 
(9)
KRT10 c.482T>C p.leu161Ser Collodion baby Focal blisters
Hyperkeratosis
PPK
yes NT
XIV
EI
F/38 No 
(10)
KRT10 c.482T>C p.leu161Serc Erosions Focal erosions
Hyperkeratosis
yes yes
XV
EI
M/42 No 
(11)
KRT10 c.452A>C p.Gln151Pro Blistering
Erosions
Erythroderma
Blistering
Hyperkeratosis
yes NT
XVI
IBS
F/29 Adopted 
(12)
No mutation found Unknown Erythroderma
Blistering
Hyperkeratosis
yes NT
aNo such mutation found in 50 controls.
bAnalysed at the Department of Clinical Genetics, Aarhus University Hospital, Denmark.
cAnalysed by Dr Paul Bowden, UWCM, Cardiff, UK.
EHK: epidermolytic hyperkeratosis; LM: light microscopy; EM: electron microscopy; LEI: linear epidermolytic ichthyosis; IBS: ichthyosis bullosa of 
Siemens; PPK: palmoplantar keratoderma; ND: not diagnostic; NT: not tested.
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leukocytes (17). There seems to be a correlation between 
widespread LEI and the risk of germ-line transmission 
(22). The patient with lEI (VIII) had rippled and hyper-
keratotic streaks on his right-side extremities, as well as 
thickened macerated skin in his right axilla (Fig. S1). 
Blood leukocytes, but no keratinocytes from affected 
skin, were available for molecular genetic analysis; no 
mutations in K1 or K10 could be detected. 
We could not identify any mutation in patient XVI. 
The patient was adopted from Korea, and had clinical 
features of IBS (Fig. S2). Mutations outside the hotspot 
region of KRT2 are possible. 
The treatment options for EI are less than satisfac-
tory. Retinoids are used in more severe cases of EI, 
but are usually moderately effective and carry a risk of 
side-effects when given systemically (24). Nine of our 
patients had been treated with systemic retinoids (etre-
tinate, acitretin, isotretinoin or alitretinoin). Of these, 
3 patients (patient I with K1 mutation and patients XIV 
and XV with K10 mutations) had acceptable treatment 
responses and are continuously on retinoid therapy. 
However, in another 2 patients (II and III) with K1 
mutations skin symptoms such as blistering and ero-
sions worsened during treatment; presumably they are 
more vulnerable to a retinoid down-regulation of K2, 
which may otherwise, to some extent, compensate for 
a mutated or missing K1 protein (14).
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